AzTrials
AzTrials

Cerebral PalsyEarly Phase 1NCT07155213

Adapted High-Intensity Virtual Reality Exergaming

A Early Phase 1 study testing Virtual reality exergaming in people with Cerebral Palsy, run by University of Alabama at Birmingham at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will test the acceptability and benefits of a home-based high-intensity virtual reality exercise program for young people with physical disabilities. The program will last 6 weeks. There will be a total of two visits to the laboratory for exercise-related health assessments. Read more about this study

Who is it for?
Ages 13 to 25 years
Conditions the study is for
Cerebral Palsy
What is being tested?
Virtual reality exergaming
Could I receive a placebo?
No, everyone receives an active treatment
How many people
4 participants
Where
1 siteUnited States
Study dates
3 Sep 2025to 1 Apr 2026
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 25 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • overweight or obese (based on CDC body mass index normative ranges for age and sex)
  • physically inactive (<150 min/week of moderate exercise)
  • Gross Motor Function Classification System level (GMFCS) levels I-IV
  • Physician clearance to participate
  • Wifi internet access at home

Who cannot join

  • Complete blindness or deafness
  • GMFCS level V
  • Unable to communicate in English
  • Prone to photosensitive seizures
  • Pregnant (due to radiation from a Dual Energy X-ray Absorptiometry [DXA] scan

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UAB Wellness Health and Research Facility

    Birmingham, Alabama, 35209

Other trials in United States

About this study

Official title: Feasibility of Vigorous Extended Reality Exergaming on Cardiometabolic Health in Youth With Mobility Disabilities: A Case Series

This study will test the acceptability and benefits of a home-based high-intensity virtual reality exercise program for young people with physical disabilities. The program will last 6 weeks. There will be a total of two visits to the laboratory for exercise-related health assessments. The program includes head-mounted displays (Meta Quest) and off-the-shelf games.

Conditions
Cerebral Palsy
Being tested
Virtual reality exergaming
Keywords
active video gaming, telehealth, telerehabilitation
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual reality exergamingBehavioural

    High-intensity active video gaming using head-mounted display.

Study groups in NCT07155213
Study groupRoleWhat they receive
Virtual Reality Exergaming InterventionExperimentalHigh-intensity active video gaming at the home.
Receives: Behavioral: Virtual reality exergaming

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total lean mass

    lbs

    Measured: week 0, week 7

  2. Total fat mass

    lbs

    Measured: Week 0, Week 7

  3. Systolic blood pressure

    mmHg

    Measured: Week 0, week 7

  4. high sensitivity C-reactive protein (hsCRP)

    mg/L

    Measured: Week 0, Week 7

  5. hemoglobin A1c (HbA1C)

    mmol/mol

    Measured: Week 0, week 7

  6. fasting insulin

    μIU/mL

    Measured: Week 0, week 7

  7. Total cholesterol

    mg/dL

    Measured: Week 0, week 7

  8. Low-density lipoprotein

    mg/dL

    Measured: Week 0, week 7

  9. High-density lipoprotein

    mg/dL

    Measured: Week 0, week 7

  10. Diastolic blood pressure

    mmHg

    Measured: Week 0, week 7

Secondary outcomes (3)
  1. Peak oxygen consumption (pVO2)

    mlkg/min

    Measured: Week 0, Week 7

  2. Total work output

    watts

    Measured: Week 0, Week 7

  3. Resting heart rate

    beats/min

    Measured: Week 0, week 7

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Sep 2025
  2. Study start3 Sep 2025
  3. Primary completion1 Feb 2026
  4. Study completion1 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Model description
Virtual reality high-intensity exercise in either the seated or standing position.
Masking
None (open label)
Enrolment
4 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07155213
Sponsor's protocol ID
300014468
Other IDs
CEDHARS Pilot 2025
Status last verified
Apr 2026
First submitted
12 Aug 2025
Last updated
13 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: All raw data will be published.

Publications

  • Lai B, Logan M, Young R, Wright A, Terrell J, Bright L, Davis D, Mendonca CJ. Feasibility of Vigorous Extended Reality Tele-Exergaming for Cardiometabolic Health in Youth With Mobility Disabilities: Protocol for a Case Series Study. JMIR Res Protoc. 2026 Feb 27;15:e85246. doi: 10.2196/85246.

    PubMed 41773697

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Virtual reality exergaming in people with Cerebral Palsy, run by University of Alabama at Birmingham at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total lean mass (time frame: week 0, week 7). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07155213, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in